18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Inactive enzymatic mutant proteins (phosphoglycerate mutase and enolase) as sugar binders for ribulose-1,5-bisphosphate regeneration reactors

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Carbon dioxide fixation bioprocess in reactors necessitates recycling of D-ribulose1,5-bisphosphate (RuBP) for continuous operation. A radically new close loop of RuBP regenerating reactor design has been proposed that will harbor enzyme-complexes instead of purified enzymes. These reactors will need binders enabling selective capture and release of sugar and intermediate metabolites enabling specific conversions during regeneration. In the current manuscript we describe properties of proteins that will act as potential binders in RuBP regeneration reactors.

          Results

          We demonstrate specific binding of 3-phosphoglycerate (3PGA) and 3-phosphoglyceraldehyde (3PGAL) from sugar mixtures by inactive mutant of yeast enzymes phosphoglycerate mutase and enolase. The reversibility in binding with respect to pH and EDTA has also been shown. No chemical conversion of incubated sugars or sugar intermediate metabolites were found by the inactive enzymatic proteins. The dissociation constants for sugar metabolites are in the micromolar range, both proteins showed lower dissociation constant (Kd) for 3-phosphoglycerate (655–796 μM) compared to 3-phosphoglyceraldehyde (822–966 μM) indicating higher affinity for 3PGA. The proteins did not show binding to glucose, sucrose or fructose within the sensitivity limits of detection. Phosphoglycerate mutase showed slightly lower stability on repeated use than enolase mutants.

          Conclusions

          The sugar and their intermediate metabolite binders may have a useful role in RuBP regeneration reactors. The reversibility of binding with respect to changes in physicochemical factors and stability when subjected to repeated changes in these conditions are expected to make the mutant proteins candidates for in-situ removal of sugar intermediate metabolites for forward driving of specific reactions in enzyme-complex reactors.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: not found
          • Article: not found

          Separation of the phosphoric esters on the filter paper chromatogram.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Solubilization and concentration of carbon dioxide: novel spray reactors with immobilized carbonic anhydrase.

            Novel spray reactors are described that employ immobilized biocatalyst (carbonic anhydrase), enabling concentration and solubilization of emitted CO(2) by allowing catalytic contact with water spray. The reactors were fed with simulated emission gas. The performance of the reactors was investigated with respect to operation variable: emission flow rate; gas composition in the emission stream; water flow rate; area-to-volume ratio of immobilized reactor core; and the enzyme load within the core. The reactors were also investigated for pressure drop and extractability of CO(2) from the emission with single vs. multiple reactors (of combined equal volume). The biotechnological process of solubilization and concentration of CO(2) from emission exhausts or streams occurring in the spray reactors could be coupled for further biochemical/chemical conversion of the concentrated CO(2). Copyright 2004 Wiley Periodicals, Inc.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Carbon emissions. The economic benefits of the Kyoto Protocol.

              The third Conference of the Parties in Kyoto set the target of reducing greenhouse-gas emissions by an average of 5.3% with respect to 1990 values by 2008-2012. One of the main objections to the protocol's ratification is that compliance would pose an unbearable economic burden on the countries involved. But we show here that this is not the case if costs apart from the direct costs of energy production are also considered. Costs are also incurred in rectifying damage to human health, material goods, agriculture and the environment related to greenhouse-gas emissions.
                Bookmark

                Author and article information

                Journal
                Microb Cell Fact
                Microbial Cell Factories
                BioMed Central (London )
                1475-2859
                2005
                2 February 2005
                : 4
                : 5
                Affiliations
                [1 ]Department of Biotechnology, Haldia Institute of Technology, Haldia, West Bengal, India
                [2 ]Environmental Biotechnology Division, ABRD Company LLC, 1555 Wood Road, Cleveland, Ohio, 44121, USA
                [3 ]Plant Molecular Biology Division, National Chemical Laboratory, Pune 411008, India
                [4 ]Department of Ophthalmic Research, Cleveland Clinic Foundation, Area I31, 9500 Euclid Avenue, Cleveland, Ohio, 44195, USA
                Article
                1475-2859-4-5
                10.1186/1475-2859-4-5
                548675
                15689239
                7273276d-9677-4131-82b2-c2c693886861
                Copyright © 2005 De et al; licensee BioMed Central Ltd.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 1 December 2004
                : 2 February 2005
                Categories
                Research

                Biotechnology
                Biotechnology

                Comments

                Comment on this article